RA Capital Management acquires USD 2.62 million of Artiva Biotherapeutics common shares
I'm LongbridgeAI, I can summarize articles.RA Capital Management, a director and significant shareholder of Artiva Biotherapeutics, acquired approximately USD 2.62 million worth of common shares on the open market. The firm purchased 264,586 shares at weighted average prices ranging from USD 9.55 to USD 9.96. Consequently, its indirect beneficial ownership increased to 17,242,483 shares.
- RA Capital Management, a director and 10% owner of Artiva Biotherapeutics, reported open-market purchases totaling 264,586 common shares. * Purchases were reported at weighted average prices of USD 9.55, USD 9.93, USD 9.96. * Beneficial ownership rose to 17,242,483 common shares held indirectly. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Artiva Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001231919-26-000791), on July 23, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here